Covered recipient · General Payments record
JUSTIN BRADLEY WATKINS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$2,145.52
- Reported across 147 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $525.71 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $131.02 | 6 |
| Amgen Inc. | $97.27 | 5 |
| Acerta Pharma LLC | $53.65 | 3 |
| Alkermes, Inc. | $50.13 | 2 |
| ABBVIE INC. | $44.19 | 2 |
| Novo Nordisk AS | $32.04 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.15 | 1 |
| Astellas Pharma US Inc | $19.63 | 1 |
| Lilly USA, LLC | $19.27 | 1 |
| Janssen Pharmaceuticals, Inc | $18.24 | 1 |
| GlaxoSmithKline, LLC. | $18.07 | 1 |
| Organon LLC | $17.05 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.20 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312563 | CMS |
| ABBVIE INC. | $29.99 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312565 | CMS |
| Alkermes, Inc. | $26.69 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120617570 | CMS |
| Alkermes, Inc. | $23.44 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120617572 | CMS |
| Amgen Inc. | $19.86 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411308 | CMS |
| Amgen Inc. | $18.81 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411310 | CMS |
| Amgen Inc. | $18.92 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411312 | CMS |
| Amgen Inc. | $22.55 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411314 | CMS |
| Amgen Inc. | $17.13 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111736810 | CMS |
| Astellas Pharma US Inc | $19.63 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139372361 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.68 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366285 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105345047 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.28 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105605459 | CMS |
| GlaxoSmithKline, LLC. | $18.07 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116539188 | CMS |
| Indivior Inc. | $22.15 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144540365 | CMS |
| Indivior Inc. | $17.18 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144540367 | CMS |
| Indivior Inc. | $23.50 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144540369 | CMS |
| Indivior Inc. | $21.02 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144540371 | CMS |
| Indivior Inc. | $24.77 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144540373 | CMS |
| Indivior Inc. | $22.40 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144540375 | CMS |
| Janssen Pharmaceuticals, Inc | $18.24 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078218639 | CMS |
| Lilly USA, LLC | $19.27 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135111992 | CMS |
| Novartis Pharmaceuticals Corporation | $25.15 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087420882 | CMS |
| Novo Nordisk Inc | $14.75 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096972309 | CMS |
| Novo Nordisk Inc | $17.29 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097576398 | CMS |
| Organon Llc | $9.85 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213654 | CMS |
| Organon Llc | $7.20 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213656 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.